Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA approves Medtronic Percept RC Deep Brain Stimulation system

Written By Ruchika Sharma10 Jan 2024 2:30 PM IST

Dublin: Medtronic plc has announced the U.S. Food and Drug Administration (FDA) approval of its Percept RC Deep Brain Stimulation (DBS) system....

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Pfizer-Genmab Tivdak application accepted for priority review by USFDA for cervical cancer

Written By Ruchika Sharma10 Jan 2024 12:30 PM IST

New York: Pfizer Inc. and Genmab A/S have announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental...

Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple Strengths

Lupin unveils Bromfenac Ophthalmic Solution in US

Written By Ruchika Sharma10 Jan 2024 11:28 AM IST

It is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.

Good Manufacturing Practices: Govt releases Schedule M guidelines, calls for stricter quality control, recall measures

Written By Ruchika Sharma9 Jan 2024 2:30 PM IST

Some of the major changes which will happen with introduction of revised Schedule M to support upgradation of the units are introduction of...

Medicines for dialysis costing Rs 65 available for only Rs 5 in Jan Aushadhi Kendras: Amit Shah

Written By Ruchika Sharma9 Jan 2024 1:30 PM IST

Generic medicines are available at 50-90 percent of market prices at these Kendras, ensuring affordable healthcare.

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Aurobindo Pharma Telangana facility gets USFDA EIR

Written By Ruchika Sharma9 Jan 2024 12:30 PM IST

Hyderabad: Aurobindo Pharma has announced that Unit VI-B, a Formulation manufacturing facility of the Company, situated at Chitkul Village,...

Cipla, Kemwell Biopharma, Manipal forge cell therapy alliance in US

Written By Ruchika Sharma9 Jan 2024 11:32 AM IST

Mumbai: Cipla (EU) Limited, UK a wholly owned subsidiary of Cipla Limited, hereinafter referred to as Cipla has announced a strategic...

Pfizer gets European Commission nod for Talzenna, Xtandi combo for prostate cancer

Written By Ruchika Sharma9 Jan 2024 10:00 AM IST

New York: Pfizer Inc. has announced that the European Commission (EC) has approved TALZENNA (talazoparib), an oral poly ADP-ribose polymerase...

Dr Mansukh Mandaviya inaugurates CDSCO Sub Zonal Office, Central Drug Testing Laboratory in Indore

Written By Ruchika Sharma8 Jan 2024 5:00 PM IST

New Delhi: Dr Mansukh Mandaviya, Union Minister of Health and Family Welfare inaugurated the Central Drugs Standard Control Organization (CDSCO)...

Caplin Steriles gets USFDA nod for Ofloxacin Otic Solution

Written By Ruchika Sharma8 Jan 2024 2:30 PM IST

Ofloxacin Otic Solution 0.3% is used as anti-infective (antibacterial) for otic (ear) use.

Dr Reddy gets CDSCO Panel nod for oral semaglutide

Dr Reddy's Labs recalls over 8000 bottles of generic medication in US over packaging error

Written By Ruchika Sharma8 Jan 2024 11:53 AM IST

New Delhi: Dr Reddy's Laboratories is recalling over 8,000 bottles of a generic medication used to prevent rejection of a transplanted organ from...

Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilities

AbbVie, Umoja Biopharma collaborate to develop Novel In-Situ CAR-T Cell Therapies

Written By Ruchika Sharma8 Jan 2024 10:00 AM IST

North Chicago: AbbVie, and Umoja Biopharma, an early clinical-stage biotechnology company, have announced two exclusive option and license...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok